iTr35细胞亚群的免疫调节作用及其研究进展
Chenxi Yang1, Lingli Dong2, Jixin Zhong3,4
1Department of Rheumatology and Immunology, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, 430030, Hubei, China.
Clinical and experimental medicine
|February 22, 2024
概括
诱导性调节性T细胞 (iTr35) 是一种具有强大的免疫抑制能力的新型T细胞子集. 本综述巩固了有关iTr35生物学和机制的当前知识,探索了它们的诊断和治疗潜力.
科学领域:
- 免疫学 免疫学 免疫学
- 细胞生物学 细胞生物学
背景情况:
- 调节性T细胞 (Tregs) 在维持免疫平衡中发挥着至关重要的作用.
- 一个新的亚群,诱导性调节性T细胞35 (iTr35),已经出现了独特的特征.
研究的目的:
- 审查和巩固目前对 iTr35.5 的理解.
- 阐明iTr35.35的生物特征和免疫调节机制.
- 探索iTr35在疾病诊断和治疗中的潜在应用.
主要方法:
- 关于 iTr35.5 的最新研究的文献综述.
- 对表型稳定性,反应性和免疫抑制功能的分析.
- 检查IL-35生产作为一个关键机制.
主要成果:
- 与其他Tregs相比,iTr35表现出明显的表型稳定性和更高的反应性.
- 确定IL-35的产生是iTr35强大的免疫抑制功能的主要媒介.
- 对iTr35的研究还处于探索阶段,但显示出显著的前景.
结论:
- iTr35代表了免疫学研究的一个有前途的领域.
- 进一步了解iTr35机制可能会导致新的治疗策略.
- iTr35具有在疾病诊断和治疗中的未来应用潜力.
相关概念视频
Tumor Immunotherapy
524
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
524
T Cell Types and Functions
1.0K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.0K


